文献速递甲状腺与颈部外科围术期管理与 ERAS

内分泌外科患者已在使用并接纳人工智能辅助医疗

Already in the room: How endocrine surgery patients are using and embracing artificial intelligence in care.
PubMed 文献 · Surgery · 2026-08-31

该调查研究了内分泌外科门诊成人患者对人工智能(AI)的使用模式及将AI整合入外科照护的意愿。151名受访者中,66.9%过去一年使用过AI,53.6%用于获取医疗信息,90.1%愿意使用诊所认可的AI聊天机器人。隐私担忧和无实时医务人员是主要障碍。

要点

  • 多数内分泌外科患者已使用AI获取医疗信息,且高度接受诊所认可的AI工具。
  • 患者最愿意在术前准备、术后指导和手术风险获益讨论中使用AI。
  • 临床医生背书可提高患者使用AI的意愿,但隐私和无实时医务人员是障碍。

核心结论

  • 内分泌外科患者积极使用AI获取医疗信息,并对诊所整合的AI工具表现出强烈兴趣,尤其在外科医生背书时,支持经过验证的聊天机器人在围术期照护中发挥作用。

研究设计与样本

  • 对内分泌外科门诊成人患者进行问卷调查,共151名受访者(应答率71.2%),平均年龄58.8岁(标准差15.3),女性110名(72.8%)。

主要发现

  • 101名(66.9%)受访者过去一年因任何原因使用过AI,81名(53.6%)用于医疗信息,40名(26.7%)在本次就诊前获取信息。
  • AI主要用于了解诊断(71名,47.0%)、症状(68名,45.0%)和治疗选择(63名,41.7%)。
  • 136名(90.1%)表示愿意使用诊所认可的AI聊天机器人,尤其用于术前准备(97名,64.2%)、术后指导(95名,62.9%)和手术风险获益讨论(93名,61.6%)。
  • 增加使用意愿的因素包括快速响应(112名,74.2%)、易于融入日常安排(103名,68.2%)和临床医生背书(91名,60.3%)。
  • 障碍包括隐私担忧(108名,71.5%)和缺乏实时医务人员(106名,70.2%)。

临床怎么用

  • 外科医生可考虑向患者推荐经过验证的AI聊天机器人,用于围术期教育和支持,并关注隐私保护和实时医务人员可及性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients are increasingly turning to artificial intelligence tools for medical information, yet patterns of use and willingness to integrate artificial intelligence into surgical care remain poorly defined. METHODS: We conducted a survey of adult patients presenting to an endocrine surgery clinic. Participants were asked questions regarding their artificial intelligence use for obtaining medical information and completed a standardized scenario evaluating willingness to use a free, 24/7 chatbot. Associated factors queried included prior medical artificial intelligence use, medical/surgical task-specific use, and willingness to use artificial intelligence for clinical applications. RESULTS: Of 151 respondents (response rate, 71.2%; mean [standard deviation] age, 58.8 [15.3] years; 110 women [72.8%]), 101 (66.9%) reported using artificial intelligence for any reason in the past year, 81 (53.6%) used it for medical information, and 40 (26.7%) used it to gain information before their current clinic visit. Artificial intelligence was primarily used to learn more about diagnoses (71 [47.0%]), symptoms (68 [45.0%]), and treatment options (63 [41.7%]). Overall, 136 patients (90.1%) expressed willingness to use a clinic-endorsed artificial intelligence chatbot, particularly for preoperative preparation (97 [64.2%]), postoperative instructions (95 [62.9%]), and discussion of surgical risks and benefits (93 [61.6%]). Factors that increased willingness to use artificial intelligence for medical information included rapid response (112 [74.2%]), ease of integration into daily schedules (103 [68.2%]), and clinician endorsement (91 [60.3%]). Barriers included privacy concerns (108 [71.5%]) and absence of a live provider (106 [70.2%]). CONCLUSION: Endocrine surgery patients actively use artificial intelligence for medical information and demonstrate strong interest in clinic-integrated artificial intelligence tools, especially when endorsed by their surgeon, supporting a role for validated chatbots in perioperative care.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Helbing A, Druar N, Finn CB, et al. Already in the room: How endocrine surgery patients are using and embracing artificial intelligence in care. Surgery. 2026. PMID: 42767164. doi:10.1016/j.surg.2026.110578

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。